States Say $8.3B Purdue Opioid Deal Flouts Bankruptcy Rules

By Emily Field · November 12, 2020, 8:45 PM EST

A group of states on Tuesday voiced opposition to Purdue Pharma LP's $8 billion OxyContin settlement with the federal government, saying that the plan puts the bankruptcy case parties in a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Objection

Case Information

Case Title

Purdue Pharma L.P.

Case Number

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019

Recent Articles By Emily

June 24, 2024
Ark. AG Sues Pharmacy Benefit Managers Over Opioids
May 03, 2024
6 States Strike $270M Opioid Deal With Amneal
April 17, 2024
FDA's Foot-Dragging On Menthol Ban Sparks Frustration
March 26, 2024
Opioid Public Nuisance Claims 'Unique,' Ohio High Court Told
March 25, 2024
What To Watch As Opioid Litigation Goes To Ohio High Court
March 11, 2024
FDA Seeks $7.2B For Fiscal Year 2025
March 07, 2024
Sens. Tell Stores To Get Illegal E-Cigs Off Their Shelves
February 27, 2024
10th Circ. Backs FDA E-Cigarettes Marketing Denial
February 14, 2024
NYC Sues Facebook, Social Media Cos. Over Teen Addiction
January 23, 2024
W.Va. County To Face Off With Opioid Distributors At 4th Circ.